No Carolina / NY / Florida
Ph: 561.316.3330

Endo Tools Therapeutics Secures €8 million ($9.5M) in Series D Funding

Summation

  • Endo Tools Therapeutics notes the funding will be used to submit a regulatory marketing submission for its medical devices to the Food and Drug Administration in the US for soft tissue approximation.
  • Endo Tools Therapeutics affixed the CE mark to its first medical devices in the EU in 2015.
  • We believe that with the product in development, the impact on patients, the team in place and the market, this will translate into substantial economic value.

January 19, 2021

Endo Tools Therapeutics notes the funding will be used to submit a regulatory marketing submission for its medical devices to the Food and Drug Administration in the US for soft tissue approximation.

Endo Tools Therapeutics also intends to seek further reimbursement within the EU. Lastly, the funding will help to continue R&D efforts into new products and indications, collate evidence on device capabilities, develop a network of centers of excellence and grow and strengthen the organization.

The funding was led by the White Fund. The transaction is supported by new private investors and the existing investors (FPIM-SFPI, Epimède, Chagral Invest, and private investors).

“With the device’s clinical performance – as outlined in published results by users in the EU over the last few years – we believe that our technology ideally fits patients’ treatment pathways. Endo Tools Therapeutics affixed the CE mark to its first medical devices in the EU in 2015. Future FDA clearance will enable us to expand our coverage into the US market and seek wider adoption by healthcare professionals,” said Alexandre Chau, CEO of Endo Tools Therapeutics.

Michel Baijot, chairman of White Fund, commented: “We are very pleased to lead this financing round involving other private and public partners and to count Endo Tools Therapeutics as a White Fund investment. Endo Tools Therapeutics’ innovative technology could lead to changes in clinical practice. We believe that with the product in development, the impact on patients, the team in place and the market, this will translate into substantial economic value.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

- Advertisement -

spot_img

- Advertisement -

Opthea Limited Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$171.5 million (US$113.2m¹)

“We appreciate the strong support from our shareholders, and from new investors, who share our belief that sozinibercept has the potential to transform patient outcomes with superior vision gains, which continues to be a significant unmet need in wet AMD,” said Frederic Guerard, PharmD, Chief Executive Officer of Opthea Limited.

InduPro Announces $85 Million Series A Financing

InduPro notes the financing will support the advancement of the first expected clinical product candidate targeting cancer tissue based on the proximity of co-targeted pairs, from preclinical development to an expected IND filing in Q4 2025 for a Phase 1 clinical trial. It will also fuel a pipeline of novel bispecific antibodies and antibody drug conjugates (ADCs) that utilizes protein proximity for identification of novel tumor selective target pairings.

Powered By MRP Raises Series A Funding from Aries Capital Partners and Swell Collective

The Series A investment marks a pivotal moment in the company's growth trajectory as it brings together unparalleled expertise and resources to accelerate the company’s expansion plans and market presence.

By using this website you agree to accept Medical Device News Magazine Privacy Policy